Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease
Anticholinergics show therapeutic utility in the treatment of some types of dystonia and in Parkinson’s disease, however, this is accompanied by wide range of unpleasant side effects, including dry-mouth. It has been proposed that muscarinic M4 receptors, located in the striatum, could be a novel th...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.718605 |